Target/Product
Primary Focus
Research
Preclinical (CTA/ IND enabling)
Clinical (Phase 1)
Milestone Date

Combination with PD-1 / PD-L1 in solid tumor (colorectal cancer)

Phase 1 safety completion – H1 20

Preclinical development candidate H2 19
Clinic ready H2 20

Preclinical development candidate H2 19
Clinic ready H2 20

Validated targets

Lead Optimisation with development candidate in 2020

Target/Product
Primary Focus
Milestone Date

Combination with PD-1 / PD-L1 in solid tumor (colorectal cancer)

Phase 1 safety completion – H1 20

Research
Pre-clinical (CTA/ IND enabling)
Clinical (Phase 1)
Target/Product
Primary Focus
Milestone Date

Preclinical 2019
Clinic ready 2020

Research
Pre-clinical (CTA/ IND enabling)
Clinical (Phase 1)
Target/Product
Primary Focus
Milestone Date

Preclinical development candidate H2 19
Clinic ready H2 20

Research
Pre-clinical (CTA/ IND enabling)
Clinical (Phase 1)
Target/Product
Primary Focus
Milestone Date

Preclinical development candidate H2 19
Clinic ready H2 20

Research
Pre-clinical (CTA/ IND enabling)
Clinical (Phase 1)
Target/Product
Primary Focus
Milestone Date

Validated targets

Lead Optimisation with development candidate in 2020

Research
Pre-clinical (CTA/ IND enabling)
Clinical (Phase 1)